Roopa Industries Adjusts Evaluation Amid Positive Sales Growth and High Debt Concerns
Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has adjusted its evaluation amid a shift in market conditions. The company reported strong financial performance over the last three quarters, with significant growth in net sales and profit, despite facing challenges related to its debt levels.
Roopa Industries, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical landscape surrounding the stock, indicating a transition from a bearish trend to a mildly bearish stance. Key financial metrics reveal that Roopa Industries has reported positive results for the last three consecutive quarters, with net sales for the half-year reaching Rs 56.34 crore, marking a growth of 68.73%. The company also achieved its highest profit after tax (PAT) of Rs 0.76 crore and an earnings per share (EPS) of Rs 0.97 in the latest quarter. Despite these positive indicators, the stock has faced challenges, including a high debt-to-EBITDA ratio of 7.12 times, which suggests a limited capacity to service its debt obligations.
Over the past year, Roopa Industries has underperformed compared to the broader market, generating a return of -2.30% against the BSE 500's 9.52%. The stock's valuation appears attractive, with a return on capital employed (ROCE) of 5.09% and a PEG ratio of 0.4, indicating potential for growth relative to its earnings.
For those interested in tracking the latest developments, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
